These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism. Puccetti P; Fallarino F Blood Cells Mol Dis; 2008; 40(1):101-5. PubMed ID: 17881253 [TBL] [Abstract][Full Text] [Related]
23. T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase. Kahler DJ; Mellor AL Handb Exp Pharmacol; 2009; (188):165-96. PubMed ID: 19031026 [TBL] [Abstract][Full Text] [Related]
24. IFN-gamma-indoleamine-2,3 dioxygenase acts as a major suppressive factor in 4-1BB-mediated immune suppression in vivo. Kim YH; Choi BK; Kang WJ; Kim KH; Kang SW; Mellor AL; Munn DH; Kwon BS J Leukoc Biol; 2009 May; 85(5):817-25. PubMed ID: 19218483 [TBL] [Abstract][Full Text] [Related]
25. Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO? Terness P; Chuang JJ; Bauer T; Jiga L; Opelz G Blood; 2005 Mar; 105(6):2480-6. PubMed ID: 15572592 [TBL] [Abstract][Full Text] [Related]
26. Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells. Fallarino F; Orabona C; Vacca C; Bianchi R; Gizzi S; Asselin-Paturel C; Fioretti MC; Trinchieri G; Grohmann U; Puccetti P Int Immunol; 2005 Nov; 17(11):1429-38. PubMed ID: 16172135 [TBL] [Abstract][Full Text] [Related]
27. IDO expressing dendritic cells suppress allograft rejection of small bowel transplantation in mice by expansion of Foxp3+ regulatory T cells. Xie FT; Cao JS; Zhao J; Yu Y; Qi F; Dai XC Transpl Immunol; 2015 Oct; 33(2):69-77. PubMed ID: 26002283 [TBL] [Abstract][Full Text] [Related]
28. Tolerogenic splenic IDO (+) dendritic cells from the mice treated with induced-Treg cells suppress collagen-induced arthritis. Yang J; Yang Y; Fan H; Zou H J Immunol Res; 2014; 2014():831054. PubMed ID: 25405209 [TBL] [Abstract][Full Text] [Related]
29. Neem leaf glycoprotein overcomes indoleamine 2,3 dioxygenase mediated tolerance in dendritic cells by attenuating hyperactive regulatory T cells in cervical cancer stage IIIB patients. Roy S; Barik S; Banerjee S; Bhuniya A; Pal S; Basu P; Biswas J; Goswami S; Chakraborty T; Bose A; Baral R Hum Immunol; 2013 Aug; 74(8):1015-23. PubMed ID: 23628394 [TBL] [Abstract][Full Text] [Related]
31. Induction of regulatory T Cells by dendritic cells through indoleamine 2,3-dioxygenase: a potent mechanism of acquired peripheral tolerance. Trabanelli S; Ocadlikova D; Evangelisti C; Parisi S; Curti A Curr Med Chem; 2011; 18(15):2234-9. PubMed ID: 21517756 [TBL] [Abstract][Full Text] [Related]
32. Different partners, opposite outcomes: a new perspective of the immunobiology of indoleamine 2,3-dioxygenase. Orabona C; Pallotta MT; Grohmann U Mol Med; 2012 Jul; 18(1):834-42. PubMed ID: 22481272 [TBL] [Abstract][Full Text] [Related]
33. IDO: more than an enzyme. Chen W Nat Immunol; 2011 Aug; 12(9):809-11. PubMed ID: 21852775 [No Abstract] [Full Text] [Related]
35. Using an ancient tool for igniting and propagating immune tolerance: IDO as an inducer and amplifier of regulatory T cell functions. Fallarino F; Grohmann U Curr Med Chem; 2011; 18(15):2215-21. PubMed ID: 21517758 [TBL] [Abstract][Full Text] [Related]